Pilot Trial of Temsirolimus and Perifosine in Recurrent/Progressive Malignant Gliomas
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Sep 2016
At a glance
- Drugs Perifosine (Primary) ; Temsirolimus (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Therapeutic Use
- 07 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 14 Jul 2015 According to the ClinicalTrials.gov record, planned number of patients changed from 17 to 22.
- 14 Jul 2015 According to the ClinicalTrials.gov record, planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016.